# Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

> clinical trial · VERIFIED · 2026-08-14

Status: RECRUITING · Sponsor: Northwestern University · Condition: Newly Diagnosed Glioblastoma

- Company: Northwestern University
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05864534

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.